Innovation Pharmaceuticals Inc (IPIX)

[frrol]

OK... One of your points: "In solid tumors safety is good but efficacy will need to be proven in combo...Those results will be a long time from now."

Agreed, they will. Hence my post that in biotech "not happening fast enough" doesn't mean "not happening". Which you know quite well.

What point did I miss? You may be right about Brilacidin and the HDP-mimetic platform, I've been scratching my head about the "Phase 2" for the HS as well. Unless the compound is B how can it skip Phase 1?